Moderna Stock Hits 52-Week High Following Nasdaq-100 Inclusion

Key Facts

Moderna shares rose to a new 52-week high on Friday following the stock's official inclusion in the Nasdaq-100 Index. Benzinga reported that the entry into the index drove a 5% price increase, as such moves typically trigger institutional buying and ETF rebalancing across the market.

MRNA closed at $197 on October 8, 2026, prior to reaching its new annual peak during the Friday session. Meanwhile, NDAQ closed at $92.37 on October 8, 2026, as the exchange operator managed the scheduled adjustments to its benchmark technology index.